Science Applications International Corporation (SAIC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 27	$2.31	$3.01	+30.3%	—	$1.9B	—
Q3 26	$2.15	$2.58	+20.0%	—	$1.9B	—
Q2 26	$2.24	$3.63	+62.1%	—	$1.8B	—
Q1 26	$2.12	$1.92	-9.4%	—	$1.9B	—
Q4 25	$2.09	$2.57	+23.0%	—	$1.8B	—
Q3 25	$2.16	$2.61	+20.8%	—	$2B	—
Q2 25	$1.85	$2.05	+10.8%	—	$1.8B	—
Q1 25	$1.92	$1.92	0.0%	—	$1.8B	—
Q4 24	$1.44	$1.43	-0.7%	—	$1.7B	—
Q3 24	$1.69	$2.27	+34.3%	—	$1.9B	—
Q2 24	$1.62	$2.05	+26.5%	—	$1.8B	—
Q1 24	$1.82	$2.14	+17.6%	—	$2B	—
Q4 23	$1.65	$2.04	+23.6%	—	$2B	—
Q3 23	$1.73	$1.9	+9.8%	—	$1.9B	—
Q2 23	$1.68	$1.75	+4.2%	—	$1.8B	—
Q1 23	$1.77	$1.88	+6.2%	—	$2B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$7.73	—	—	$7.3B	—
FY25	—	$7.23	—	—	$7.5B	—
FY24	—	$8.98	—	—	$7.4B	—
FY23	—	$5.42	—	—	$7.7B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$4.4B	$4.5B	$4.7B	$6.4B	$7.1B	$7.4B	$7.7B	$7.4B	$7.5B	$7.3B
YoY change	+2.94%	+0.27%	+4.6%	+36.9%	+10.6%	+4.79%	+4.19%	-3.37%	+0.47%	-2.9%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	4.4B	4.5B	4.7B	6.4B	7.1B	7.4B	7.7B	7.4B	7.5B	7.3B
Cost of revenue	4B	4B	4.2B	5.7B	6.3B	6.5B	6.8B	6.6B	6.6B	6.4B
Gross profit	439M	411M	464M	706M	792M	859M	888M	872M	892M	872M
Gross margin	9.88%	9.23%	9.96%	11.1%	11.2%	11.6%	11.5%	11.7%	11.9%	12%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	166M	155M	158M	288M	352M	344M	374M	373M	339M	350M
Operating expenses	166M	155M	158M	288M	348M	343M	374M	370M	331M	351M
Operating income	273M	256M	306M	418M	444M	516M	514M	502M	561M	521M
Operating margin	6.15%	5.75%	6.57%	6.55%	6.29%	6.98%	6.67%	6.74%	7.5%	7.17%
Non-operating income, net	-9M	2M	-83M	-42M	-51M	-53M	-21M	238M	-7M	-6M
Pretax income	212M	214M	170M	286M	271M	358M	375M	620M	428M	387M
Income tax	69M	35M	33M	57M	60M	79M	72M	143M	66M	29M
Net income	143M	179M	137M	229M	211M	279M	303M	477M	362M	358M
Net margin	3.22%	4.02%	2.94%	3.59%	2.99%	3.77%	3.93%	6.41%	4.84%	4.93%
EBITDA	327M	304M	356M	555M	626M	682M	663M	643M	692M	664M
EPS	3.33	4.13	3.16	3.87	3.6	4.81	5.42	8.98	7.23	7.73
Diluted EPS	3.22	4.02	3.11	3.83	3.56	4.77	5.38	8.88	7.17	7.7

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Revenue	1.9B	1.7B	1.8B	1.8B	2B	1.8B	1.9B	1.8B	1.9B	1.8B	1.9B	1.9B
Cost of revenue	1.7B	1.5B	1.6B	1.6B	1.7B	1.6B	1.7B	1.6B	1.6B	1.5B	1.7B	1.6B
Gross profit	229M	192M	213M	210M	237M	232M	209M	215M	227M	221M	249M	239M
Gross margin	12.1%	11.1%	11.5%	11.6%	12%	12.6%	11.1%	12.2%	12.2%	12.6%	13.1%	12.7%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	87M	114M	85M	77M	83M	94M	89M	75M	101M	85M	83M	87M
Operating expenses	86M	353M	82M	76M	77M	96M	88M	76M	99M	88M	70M	87M
Operating income	143M	-161M	131M	134M	160M	136M	121M	139M	128M	133M	179M	152M
Operating margin	7.55%	-9.27%	7.09%	7.37%	8.1%	7.4%	6.45%	7.86%	6.86%	7.6%	9.39%	8.09%
Non-operating income, net	-2M	232M	-2M	-3M	-2M	0	-5M	—	-1M	0	-1M	—
Pretax income	114M	48M	95M	100M	126M	107M	86M	108M	94M	99M	145M	119M
Income tax	21M	9M	18M	19M	20M	9M	18M	-19M	16M	14M	30M	17M
Net income	93M	39M	77M	81M	106M	98M	68M	127M	78M	85M	115M	102M
Net margin	4.91%	2.25%	4.17%	4.46%	5.36%	5.33%	3.62%	7.18%	4.18%	4.86%	6.03%	5.43%
EBITDA	175M	-133M	164M	165M	193M	170M	152M	174M	165M	173M	218M	191M
EPS	1.79	0.75	1.49	1.59	2.15	2.02	1.43	2.72	1.7	1.89	2.63	2.41
Diluted EPS	1.76	0.74	1.48	1.58	2.13	2	1.42	2.71	1.69	1.87	2.61	2.38

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	3.6B	3.3B	2.9B	—	5.6B	4.7B	5.7B	6.8B	5.4B	4.7B	5.5B
Enterprise value	4.5B	4.2B	4.8B	—	8.1B	7.3B	8.2B	8.9B	7.8B	7.2B	8.1B
Shares outstanding	44.5M	43.3M	43.4M	58.4M	58.1M	57.6M	55.3M	53.1M	50.1M	46.3M	46.3M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	25.3	18.5	21.3	—	26.4	16.9	18.9	14.2	15	13.2	15.3
P/S	0.82	0.75	0.63	—	0.79	0.64	0.74	0.91	0.73	0.65	0.74
P/B	10.4	10.1	1.94	—	3.59	2.9	3.37	3.8	3.44	3.14	3.84
EV/EBITDA	13.6	13.8	13.4	—	13	10.7	12.3	13.9	11.2	10.9	10.8
EV/Sales	1	0.94	1.02	—	1.15	0.99	1.06	1.2	1.04	0.99	1.1
Earnings yield	3.95%	5.39%	4.7%	—	3.78%	5.9%	5.28%	7.04%	6.67%	7.6%	6.54%
FCF yield	7.12%	5.88%	5.35%	—	12.7%	10.2%	8.83%	5.44%	8.44%	12.2%	9.21%
PEG	—	—	—	—	—	—	—	—	—	—	-1.34

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	9.88%	9.23%	9.96%	11.1%	11.2%	11.6%	11.5%	11.7%	11.9%	12%	12.7%
Operating margin	6.15%	5.75%	6.57%	6.55%	6.29%	6.98%	6.67%	6.74%	7.5%	7.17%	8.09%
Net margin	3.22%	4.02%	2.94%	3.59%	2.99%	3.77%	3.93%	6.41%	4.84%	4.93%	5.13%
ROE	41%	54.7%	9.14%	16%	13.6%	17.1%	17.8%	26.7%	23%	23.9%	25.7%
ROA	7%	8.63%	3%	4.86%	3.69%	4.86%	5.47%	8.98%	6.9%	6.69%	7.01%
ROIC	15.5%	17.7%	7.36%	10%	8.43%	9.5%	10.1%	9.81%	12.1%	12%	12.3%
Return on tangible assets	-170.2%	-1.6K%	-10.7%	-23.2%	-9.92%	-11.9%	-13.2%	-21.9%	-18%	-17.4%	-20.5%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	1.45	1.37	1.6	1.27	1.01	0.93	1.06	0.98	0.83	1.2	1.2
Quick ratio	1.33	1.27	1.52	1.19	0.95	0.89	1	0.97	0.83	1.2	1.2
Debt / equity	3	3.13	1.39	1.47	1.75	1.66	1.48	1.26	1.52	1.79	1.88
Debt / assets	0.51	0.49	0.46	0.44	0.48	0.47	0.46	0.42	0.46	0.5	0.5
Net debt / EBITDA	2.56	2.89	5.2	3.43	4.07	3.82	3.65	3.35	3.38	3.77	3.45
Interest coverage	5.08	5.86	4.21	4.18	3.22	4.41	4.18	6.17	4.4	4.02	4.44
Effective tax rate	32.5%	16.4%	19.4%	19.9%	22.1%	22.1%	19.2%	23.1%	15.4%	7.49%	16.8%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	99.8	102.9	107.4	109.2	121.4	128.4	139.3	140.2	149.3	156.8	167.1
EPS (basic)	3.33	4.13	3.16	3.87	3.6	4.81	5.42	8.98	7.23	7.73	7.73
EPS (diluted)	3.22	4.02	3.11	3.83	3.56	4.77	5.38	8.88	7.17	7.7	8.58
Book value per share	7.84	7.55	34.5	24.4	26.7	28.3	30.8	33.6	31.5	32.4	34.2
FCF per share	5.8	4.5	3.59	7.48	12.2	8.37	9.17	6.95	9.14	12.5	14.5
Cash per share	4.72	3.33	5.46	3.22	2.94	1.84	1.97	1.77	1.12	3.93	3.01
Capex per share	0.34	0.51	0.65	0.36	—	—	—	—	—	0.69	0.96

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	0.34%	0.49%	0.6%	0.33%	—	—	—	—	—	0.44%	0.55%
Capex / operating cash flow	4.7%	9.44%	25.2%	4.67%	—	—	—	—	—	5.25%	6.21%
Payout ratio	37.8%	30.2%	38.7%	38%	41.2%	30.8%	27.4%	16.6%	20.7%	19.6%	17.3%
Dividend yield	1.49%	1.63%	1.82%	—	1.56%	1.82%	1.45%	1.17%	1.38%	1.49%	1.13%

Yield

1.13%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.37

ex-dividend Oct 9, 2026

Payout ratio

17%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Oct 9, 2026upcoming	$0.37
Jul 10, 2026	$0.37
Apr 10, 2026	$0.37
Jan 14, 2026	$0.37

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Revenue	$1.9B	$1.7B	$1.8B	$1.8B	$2B	$1.8B	$1.9B	$1.8B	$1.9B	$1.8B	$1.9B	$1.9B
YoY change	-0.73%	-11.7%	-8.93%	+1.91%	+4.27%	+5.81%	+1.62%	-2.7%	-5.57%	-4.79%	+1.55%	+6.27%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	210M	144M	237M	188M	171M	106M	109M	94M	56M	182M
Receivables	419M	674M	1.1B	1.1B	962M	1B	936M	914M	1B	853M
Inventory	71M	68M	74M	84M	78M	64M	71M	3M	—	—
Total current assets	901M	950M	1.4B	1.4B	1.3B	1.3B	1.2B	1.1B	1.2B	1.2B
Property, plant & equipment	53M	54M	96M	274M	337M	302M	243M	236M	261M	296M
Goodwill & intangibles	2.1B	2.1B	5.8B	5.7B	7.8B	8.1B	7.8B	7.5B	7.3B	7.4B
Total assets	2B	2.1B	4.6B	4.7B	5.7B	5.7B	5.5B	5.3B	5.2B	5.4B
Accounts payable	329M	397M	455M	527M	517M	612M	624M	567M	631M	500M
Short-term debt	25M	41M	24M	70M	68M	148M	31M	77M	313M	19M
Total current liabilities	623M	695M	897M	1.1B	1.3B	1.4B	1.1B	1.2B	1.4B	982M
Long-term debt	1B	983M	2.1B	2B	2.7B	2.6B	2.5B	2.2B	2.1B	2.7B
Total liabilities	1.7B	1.7B	3.1B	3.3B	4.2B	4.1B	3.8B	3.5B	3.7B	3.9B
Shareholders' equity	349M	327M	1.5B	1.4B	1.6B	1.6B	1.7B	1.8B	1.6B	1.5B
Total debt	1B	1B	2.1B	2.1B	2.7B	2.7B	2.5B	2.2B	2.4B	2.7B
Net debt	837M	880M	1.9B	1.9B	2.5B	2.6B	2.4B	2.2B	2.3B	2.5B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Cash & short-term investments	—	—	—	—	—	—	—	—	45M	182M	109M	126M
Receivables	—	—	—	—	—	—	—	—	1B	853M	962M	996M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	—	—	—	—	—	—	—	—	1.3B	1.2B	1.2B	1.3B
Property, plant & equipment	—	—	—	—	—	—	—	—	270M	296M	295M	332M
Goodwill & intangibles	2.9B	—	—	—	—	—	—	—	7.5B	7.4B	7.3B	7.3B
Total assets	4.3B	—	—	—	—	—	—	—	5.4B	5.4B	5.3B	5.4B
Accounts payable	—	—	—	—	—	—	—	—	627M	500M	634M	597M
Short-term debt	—	—	—	—	—	—	—	—	12M	19M	26M	33M
Total current liabilities	—	—	—	—	—	—	—	—	1.1B	982M	1B	1.1B
Long-term debt	—	—	—	—	—	—	—	—	2.6B	2.7B	2.6B	2.7B
Total liabilities	—	—	—	—	—	—	—	—	3.9B	3.9B	3.9B	4B
Shareholders' equity	—	—	—	—	—	—	—	—	1.5B	1.5B	1.4B	1.4B
Total debt	—	—	—	—	—	—	—	—	2.6B	2.7B	2.7B	2.7B
Net debt	—	—	—	—	—	—	—	—	2.6B	2.5B	2.6B	2.6B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	143M	179M	137M	229M	211M	279M	303M	477M	362M	358M
Depreciation & amortization	53M	46M	47M	131M	179M	165M	157M	142M	140M	149M
Stock-based compensation	31M	27M	45M	37M	42M	46M	48M	68M	53M	64M
Change in working capital	94M	-32M	-139M	2M	198M	-31M	78M	-70M	-44M	28M
Operating cash flow	319M	233M	111M	450M	648M	492M	564M	594M	501M	609M
Capital expenditure	-15M	-22M	-28M	-21M	—	—	—	—	—	-32M
Investing cash flow	-17M	-22M	-1B	-47M	-1.2B	-256M	-11M	341M	1M	-248M
Dividends paid	-54M	-54M	-53M	-87M	-87M	-86M	-83M	-79M	-75M	-70M
Share repurchases	-180M	-186M	-69M	-197M	-34M	-226M	-267M	-382M	-558M	-445M
Financing cash flow	-247M	-261M	938M	-455M	464M	-301M	-493M	-725M	-498M	-235M
Net change in cash	55M	-50M	21M	-52M	-73M	-65M	60M	210M	4M	126M
Free cash flow	258M	195M	156M	437M	709M	482M	507M	369M	458M	577M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26	Q1 27	Q2 27
Net income	—	—	—	—	—	—	—	—	78M	85M	115M	102M
Depreciation & amortization	—	—	—	—	—	—	—	—	38M	40M	40M	39M
Stock-based compensation	—	—	—	—	—	—	—	—	26M	13M	13M	15M
Change in working capital	—	—	—	—	—	—	—	—	-7M	103M	-25M	-57M
Operating cash flow	—	—	—	—	—	—	—	—	129M	258M	127M	146M
Capital expenditure	—	—	—	—	—	—	—	—	-9M	-8M	-9M	-15M
Investing cash flow	—	—	—	—	—	—	—	—	-12M	-11M	1M	-17M
Dividends paid	—	—	—	—	—	—	—	—	-17M	-17M	-17M	-16M
Share repurchases	—	—	—	—	—	—	—	—	-95M	-98M	-188M	-98M
Financing cash flow	—	—	—	—	—	—	—	—	83M	-110M	-201M	-110M
Net change in cash	—	—	—	—	—	—	—	—	200M	137M	-73M	19M
Free cash flow	97M	52M	92M	132M	134M	100M	92M	115M	120M	250M	118M	131M

Science Applications International Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement